$HCA HCA Healthcare Q4 2024 Adj EPS $6.22 Beats $6.13 Estimate Sales $18.29B Beat $18.23B Estimate
HCA Healthcare, $HCA, Q4 FY2024 Results: 📊 Adj EPS: $6.22 🟢 💰 Revenue: $18.29B 🟢 📈 Net Income: $1.44B 🏥 Admissions: +3.0%; Inpatient surgeries: +2.8% 🌪️ Impact: $0.60/share from hurricane disruptions 🔮 2025 Outlook: Revenue $72.8-$75.8B
HCA’s stock gains as earnings beat and company raises dividend https://t.co/h8nXHqeUGm
HCA Healthcare reported its fourth-quarter 2024 earnings, posting an adjusted earnings per share (EPS) of $6.22, surpassing analysts' expectations of $6.12. The company's revenue reached $18.29 billion, exceeding the forecast of $18.22 billion. HCA's net income for the quarter was $1.44 billion, with a 3.0% increase in admissions and a 2.8% rise in inpatient surgeries. The company also noted a $0.60 per share impact from hurricane disruptions. Looking ahead, HCA projected its 2025 revenue to be between $72.8 billion and $75.8 billion. Additionally, HCA's shares rose by 1.8% to $325.36 following the earnings announcement, and Wendy Warren has been appointed as the Chief Ethics Officer.